Yingchuan Susan Sun

Yingchuan Susan Sun currently serves as the Scientific Director for Oncology Development Solid Tumor at AbbVie, a position held since February 2024. Prior to this role, Yingchuan held various positions at ImmunoGen, Inc., including Director and Associate Director of Clinical Research from April 2020 to February 2024. Earlier experience includes significant roles at Novartis Institutes for BioMedical Research, ranging from Associate Clinical Scientist to Clinical Trial Associate, as well as positions in Global Discovery Chemistry. Yingchuan's career commenced at OSI Pharmaceuticals as a Senior Research Associate and included a role at GlaxoSmithKline in Regulatory Affairs. Yingchuan holds a M.S. in Organic Chemistry from the University of Louisville, an MBA in Health Sector Management from Boston University, and a B.S. in Pharmaceutical Science from China Pharmaceutical University.